Clinical Trial Update: S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer [Phase 2]

View source ↗

Summary

Clinical trial update states that a Phase 2 study of tirapazamine plus cisplatin in patients with metastatic, recurrent, or refractory cervical cancer has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Tirapazamine (tirapazamine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED